Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics

NCT02865564 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2024-01-30

No results posted yet for this study

Summary

The aim of the study is to elucidate the relationship between postnatal antibiotic administration on development of gut microbiota and possible protective influence of simultaneously administration of probiotic during antibiotic therapy on development of gut microbiota, functional gastrointestinal disorders of infancy, weight gain and body composition.

Conditions

  • Gastrointestinal Diseases
  • Colic

Interventions

DIETARY_SUPPLEMENT

Lactobacillus reuteri DSM 17938

DIETARY_SUPPLEMENT

Placebo

DRUG

ampicillin and gentamicin

Sponsors & Collaborators

  • University of Ljubljana

    collaborator OTHER
  • University Medical Centre Ljubljana

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
21 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865564 on ClinicalTrials.gov